Yemen | Programme areas | Schistosomiasis (bilharzia)

Schistosomiasis (bilharzia)

Print PDF

Launch of the schistosomiasis elimination campaign in December 2009 in HajjaLaunch of the schistosomiasis elimination campaign, December 2009, Hajja

Schistosomiasis burden in Yemen

Around 3 million people are known to be infected with schistosomiasis (bilharzia) in Yemen, although this figure is believed to be an underestimate of the actual disease burden. Both types, urinary and intestinal, are prevalent in the country.

Transmission occurs in a large proportion of the country, with the mountainous areas in the western part of the country appearing to be most severely affected. WHO in coordination with the Ministry of Public Health and Population and the Schistosomiasis Control Initiative has developed a risk map of schistosomiasis prevalence in Yemen to improve estimates of the population infected and at risk.

Schistosomiasis control

WHO and the World Bank have technically and financially supported the Ministry of Public Health and Population in the planning, implementation and evaluation of national schistosomiasis elemination campaigns since 2008. US$ 28 million has been allocated for the Ministry campaign for 2010–2015, supported jointly the Schistosomiasis Control Initiative, the World Bank and WHO.

The treatment will cover schools and communities, and will be synchronized as much as possible with broader treatment programmes. Schools and communities involved in longitudinal monitoring will be revisited annually.

Related link



Key health-related statistics

Total population (000s) 27 426
Total health expenditure (% of general government expenditure) 3.9
Primary health care units and centres (per 10 000 population) 1.6
Life expectancy 65.3

Source: Framework for health information systems and core indicators for monitoring health situation and health system performance, 2018

See Yemen country profile

Regional Health Observatory

Contact us

WHO Representative
PO Box 543